Evidence map›Paper›PMID 41341235›Full record

ArticlePsychoradiology2025

Systematic review and meta-analysis of brain neuroimaging abnormalities in COVID-19 patients and survivors.

Peng Li, Shuyu Ni, Xiao Lin, Zengbo Ding, Na Zeng, Yimiao Zhao, Huan Mei, Xuan Chen, Nan Gao, Hanliang Wei and 15 more

Abstract read
In one paragraph

Article in Psychoradiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Peng LiPeking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University, Beijing 100191, China.ORCID https://orcid.org/0000-0002-6260-8383
Shuyu NiNational Institute on Drug Dependence and Beijing Key Laboratory on Drug Dependence Research, Peking University, Beijing 100191, China.
Xiao LinPeking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University, Beijing 100191, China.ORCID https://orcid.org/0000-0002-0495-1220
Zengbo DingNational Institute on Drug Dependence and Beijing Key Laboratory on Drug Dependence Research, Peking University, Beijing 100191, China.
Na ZengNational Institute on Drug Dependence and Beijing Key Laboratory on Drug Dependence Research, Peking University, Beijing 100191, China.
Yimiao ZhaoNational Institute on Drug Dependence and Beijing Key Laboratory on Drug Dependence Research, Peking University, Beijing 100191, China.
Huan MeiNational Institute on Drug Dependence and Beijing Key Laboratory on Drug Dependence Research, Peking University, Beijing 100191, China.
Xuan ChenDepartment of Psychiatry, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453000 Henan, China.
Nan GaoPeking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University, Beijing 100191, China.
Hanliang WeiInstitute of Brain Science and Brain-inspired Research, Shandong First Medical University (Shandong Academy of Medical Sciences), Jinan 250117 Shandong, China.
Tong LiPeking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University, Beijing 100191, China.
Yingbo YangInstitute of Brain Science and Brain-inspired Research, Shandong First Medical University (Shandong Academy of Medical Sciences), Jinan 250117 Shandong, China.
Beini YangSchool of Public Health, Peking University, Beijing 100191, China.
Ye TianDepartment of Life Science and Medicine, Harbin Institute of Technology, Harbin 264209, China.
Norimichi HaraSchool of Basic Medical Sciences, Peking University, Beijing 100191, China.
Tao WangInstitute of Brain Science and Brain-inspired Research, Shandong First Medical University (Shandong Academy of Medical Sciences), Jinan 250117 Shandong, China.
Jinyuan ZhangInstitute of Brain Science and Brain-inspired Research, Shandong First Medical University (Shandong Academy of Medical Sciences), Jinan 250117 Shandong, China.
Wei YanPeking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University, Beijing 100191, China.
Junliang YuanPeking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University, Beijing 100191, China.
Ying HanNational Institute on Drug Dependence and Beijing Key Laboratory on Drug Dependence Research, Peking University, Beijing 100191, China.
Kai YuanPeking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University, Beijing 100191, China.
Le ShiPeking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University, Beijing 100191, China.
Jie ShiNational Institute on Drug Dependence and Beijing Key Laboratory on Drug Dependence Research, Peking University, Beijing 100191, China.
Yanping BaoNational Institute on Drug Dependence and Beijing Key Laboratory on Drug Dependence Research, Peking University, Beijing 100191, China.ORCID https://orcid.org/0000-0002-1881-0939
Lin LuPeking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University, Beijing 100191, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Accumulating evidence indicates that COVID-19 may cause neurological complications detectable on brain imaging. Yet, the overall prevalence, modality-specific characteristics, and clinical implications of these neuroimaging abnormalities have not been systematically summarized through comprehensive quantitative synthesis. Methods: We searched the PubMed, Web of Science, Scopus, Embase, Cochrane Library, and China National Knowledge Infrastructure (CNKI) databases, and Wanfang for original articles published up to August 5, 2025. The pooled proportions of brain-imaging findings on computed tomography (CT), magnetic resonance imaging (MRI), and electroencephalography (EEG), including hemorrhage, microbleeds, ischemia, stroke, encephalitis, background activity abnormality, periodic or rhythmic activity, and epileptiform discharge, were estimated using a random-effects model. This study was conducted according to PRISMA guidelines. Results: Eighty-three eligible studies that included 9466 COVID-19 patients were included in the meta-analysis. Pooled results from 27 studies, including 3081 patients, showed that more than two-fifths (42.60%) of patients who underwent CT/MRI had objective brain abnormalities. The most frequently reported abnormalities on CT/MRI were changes in white matter and non-specific stroke. Twenty-five EEG studies, including 1273 patients, reported epileptiform discharges in one-fifth (20.54%) of cases. The systematic review of long-term brain imaging manifestations in COVID-19 survivors also found common changes in brain microstructure and function. Conclusion: While these findings offer insights into the potential pathological mechanisms of neuroimaging abnormalities in COVID-19 patients, the high heterogeneity and variability across studies highlight the need for cautious interpretation. It will be necessary to conduct large-scale longitudinal studies with extended follow-up periods in order to validate these neuroimaging findings and clarify the long-term neuropsychiatric consequences of COVID-19.

Indexed as

brainCOVID-19CTEEGimagingMRISARS-CoV-2

Identifiers

PMID41341235
PMCPMC12669897

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.